Anti‐inflammatory properties of desloratadine

Clinical and Experimental Allergy - Tập 34 Số 9 - Trang 1342-1348 - 2004
Devendra K. Agrawal1
1Center for Allergy, Asthma and Immunology, Creighton University School of Medicine, Omaha, NE, USA

Tóm tắt

SummaryBackground Allergic rhinitis (AR) is associated with robust infiltration of immune cells and mediators that may contribute to clinical manifestations of the disease.Objective To review the complex immune effector mechanisms involved in the allergic response and discuss their effects on the pathophysiological and clinical manifestations of AR. Desloratadine, a novel antihistamine, was used as a probe with the goal of attaining a better understanding of the inflammatory processes underlying the allergic response.Methods Data were obtained from abstracts and peer‐reviewed journals. The pathophysiology of the allergic response has been extensively studied. This paper presents only data from studies that used desloratadine at physiologically relevant concentrations.Results Key mediators involved in the allergic response and in pathophysiological and clinical manifestations of the immune response were reviewed. Desloratadine was used as a probe to further elucidate the mechanisms involved during an allergic response.Conclusions Some have proposed a link between the pathophysiology of AR and the clinical manifestation of symptoms. Desloratadine, a new‐generation antihistamine, has demonstrated anti‐inflammatory effects in vitro; indeed, desloratadine is capable of intervening at various points in the immune cascade. Although in vitro results do not necessarily correlate with clinical efficacy, the anti‐inflammatory properties of desloratadine may contribute to its efficacy in patients with AR, allergy‐induced asthma, and other related allergic conditions. Antihistamines that modulate in the immune system at various stages may optimize treatment of allergic disease.

Từ khóa


Tài liệu tham khảo

Meltzer EO., 1997, The prevalence and medical and economic impact of allergic rhinitis in the United States, J Allergy Clin Immunol, 99, S805

10.1517/13543784.11.2.259

Nathan RA, 1997, Prevalence of allergic rhinitis in the United States, J Allergy Clin Immunol, 99, S808, 10.1016/S0091-6749(97)80040-1

Allergic rhinitis: diagnosis and complications. Patient Care Fall 2000; 8–16.

10.1067/mai.2001.118891

10.1034/j.1398-9995.2000.00526.x

Branco‐Ferreira M, 2001, Antihistamines and serum adhesion molecule levels, Allergy Immunol (Paris), 33, 233

10.1016/S1081-1206(10)63219-X

10.1034/j.1600-0625.2000.009002118.x

10.1016/S0091-6749(98)70256-8

Assanasen P, 2002, Antiallergic anti‐inflammatory effects of H1‐antihistamines in humans, Clin Allergy Immunol, 17, 101

10.1016/S0091-6749(99)70308-8

10.1016/S0091-6749(97)70125-8

Gelfand EW., 2002, Role of histamine in the pathophysiology of asthma, immunomodulatory and anti-inflammatory activities of H(1)-receptor antagonists, 113, 2

10.2165/00044011-200222002-00003

Meltzer E., 2002, Allergic rhinitis, a systemic inflammatory process, 7

Meltzer E, 2001, Efficacy and tolerability of once‐daily 5 mg desloratadine, an H1‐receptor antagonist, in patients with seasonal allergic rhinitis, assessment during the spring and fall allergy seasons, 21, 25

10.1016/S1081-1206(10)62086-8

Ring J, 2001, Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria, a randomized, double-blind, placebo-controlled study, 40, 1

Monroe E, 2003, Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria, a double-blind, randomized, placebo-controlled trial, 48, 535

10.1034/j.1398-9995.2001.00082.x

Geha RS, 2001, Desloratadine, a new, nonsedating, oral antihistamine, 107, 751

Kreutner W, 2000, Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication, receptor selectivity, antihistaminic activity, and antiallergenic effects, 50, 345

Anthes J, 2000, Functional characterization of desloratadine and other antihistamines in human histamine H1 receptors, Allergy, 55, 277

10.1016/S0014-2999(02)02049-6

10.1111/j.1365-2222.1997.tb00745.x

10.1016/0091-6749(94)90359-X

10.1016/0006-2952(94)90478-2

Leurs R, 2002, H1‐antihistamines, inverse agonism, anti-inflammatory actions and cardiac effects, 32, 489

10.1517/13543784.10.3.547

Cyr MM, 2002, The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis, a placebo-controlled randomized study, 109, S117

Agrawal DK, 2003, Effect of desloratadine (DL) on the apoptosis of human blood eosinophils, Ann Allergy Asthma Immunol, 90, 100

10.1067/mai.2003.136

10.1111/j.1398-9995.1995.tb01133.x

10.1067/mai.2001.116861

10.1111/j.1365-2222.1997.tb01154.x

10.1111/j.1600-0625.1995.tb00257.x

10.1046/j.1365-2222.2001.01130.x

10.1016/S0091-6749(03)81018-7

Thông tin
Thông tin xuất bản

Clinical and Experimental Allergy

Tập 34 Số 9

1342-1348

Thông tin tác giả